Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of apatinib for inoperable or advanced gastric cancer
ChiCTR1800015701Phase 4Recruiting
- Sponsor
- Shandong Cancer Hospital
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of latanoprost in gastric cancer (GC), sponsored by Shandong Cancer Hospital. Started Apr 2018; status: recruiting.
02
Drugs
latanoprost
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR1800015701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015701.